164 results on '"Petruccelli S"'
Search Results
2. Individualized HBIG withdrawal in an historical cohort of liver transplant recipients in Italy
3. Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5)
4. Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study
5. The Impact of Everolimus on Renal Function in Maintenance Liver Transplantation
6. Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5)
7. The “You Are Not Alone” Care Program for Liver Transplantation
8. Influence of the KDEL signal, DMSO and mannitol on the production of the recombinant antibody 14D9 by long-term Nicotiana tabacum cell suspension culture
9. Immunochemical characterization of Glycine max L. Merr. var Raiden, as a possible hypoallergenic substitute for cowʼs milk-allergic patients
10. Gamma-glutamyltransferase in fine-needle liver biopsies of subjects with chronic hepatitis C
11. Everolimus vs Mycophenolate Mofetil in Combination With Tacrolimus: A Propensity Score-matched Analysis in Liver Transplantation
12. C01/049 HEPATITIS C VIRUS-POSITIVE (HCV) CHRONIC ACTIVE HEPATITIS (CAH): A RANDOMIZED, CONTROLLED TRIAL OF IFN±COLCHICINE
13. Crystallization of waxes in sunflowerseed oil: Effects of an inhibitor
14. Switch to Everolimus for Sirolimus-Induced Pneumonitis in a Liver Transplant Recipient—Not All Proliferation Signal Inhibitors Are the Same: A Case Report
15. Switch to Tacrolimus for Cyclosporine-Induced Gynecomastia in Liver Transplant Recipients
16. Transjugular intrahepatic portosystemic shunt for hepatitis C virus-related portal hypertension after liver transplantation
17. Alcohol drinking after liver transplantation is associated with graft injury
18. Protocols cure diseases, not patients: flaccid paresis in post-NSTEMI statin treatment
19. The impact of everolimus on renal function in maintenance liver transplantation
20. Sympotms prevalence and beliefs in maintenance liver transplant patients
21. A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation
22. You Are Not Alone: the Health Promoting Hospital care program for liver transplantation
23. La qualità dei protocolli per la gestione dei cateteri venosi centrali
24. Avoiding calcineurin inhibitors in the early post-operative course in high-risk liver transplant recipients: Preliminary results of the protect trial
25. Liver fat accumulation and isolated islets function in non-diabetic and type 2 diabetic subjects
26. A non-meld based allocation algorithm for HCC patients undergoing liver transplantation allows favorable results: The Tuscany experience
27. PREVALENZA DEL DIABETE MELLITO (dm) NEI SOGGETTI IN ATTESA DI TRAPIANTO DI FEGATO
28. Liver transplantation for non-Milan HCC patients
29. Ecografia interventistica nel trattamento delle complicanze del trapianto di fegato: esperienza su 700 casi
30. HEPATOSTEATOSIS AND ISLET ISOLATION
31. Fattori predittivi di sopravvivenza e di recidiva nel trapianto di fegato per carcinoma epatocellulare
32. Prevalenza del diabete mellito (DM) nei soggetti in attesa di trapianto di fegato. Esperienza del Centro di Pisa
33. Lo sviluppo di una metodologia operativa nel processo di valutazione del paziente candidato a trapianto di fegato
34. Helicobacter pylori infection: what happen in patients with diabetes mellitus?
35. Prevalence of Helicobacter pylori Infection in Patients Affected with Chronic C Hepatitis
36. Efficacia della terapia combinata ribavirina-interferone nel trattamento di pazienti resistenti a un primo ciclo di terapia convemzionale
37. Efficacia antivirale del trattamento combinato ribavirina-interferone nell'epatite cronica da virus C
38. Antiviral effect of ribavirin plus interferon in chronic hepatitis C
39. Diagnostic accuracy of a new enzyme immunoassay for the diagnosis of Helicobacter Pylori infection on stool specimens
40. Utility of combination therapy with ribavirin plus interferon on chronic hepatitis C patients previously resistant to interferon
41. Anti-NS4 serum levels during interferon-alfa therapy in chronic hepatitis C
42. Helicobacter pylori infection is associated with an increased prevalence of serum immunologic abnormalities in chronic hepatitis C patients
43. Combination therapy with interferon alpha and ribavirin in interferon alpha relapsers
44. Combination therapy with interferon alfa and ribavirin in interferon alfa relapsers
45. Chronic Active Hepatitis (CAH) due to Hepatitis C Virus (HCV): a randomized trial of IFN +/- Colchicine
46. Hepatitis C Virus-positive (HCV) Chronic Active Hepatitis (CAH): a randomized controlled trial of IFN ? Colchicine
47. Interferon-alpha treatment in chronic hepatitis C: modulation of IFN-gamma receptor density on peripheral blood lymphocytes
48. Hepatitis C Virus-positive (HCV) Chronic Active Hepatitis (CAH): a randomized controlled trial of IFN +/- Colchicine
49. Chronic active hepatitis (CAH) due to hepatitis C virus (HCV): a double-blind, randomized trial of IFN ± colchicine
50. Double-blind, randomized trial of IFN±colchicine in anti HCV-positive chronic active Hepatitis (CAH)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.